Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Voriconazole"" wg kryterium: Temat


Tytuł :
Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
Autorzy :
El-Emam GA; Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Girgis GNS; Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
El-Sokkary MMA; Department of Microbiology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
El-Azeem Soliman OA; Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Abd El Gawad AEGH; Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Pokaż więcej
Źródło :
International journal of nanomedicine [Int J Nanomedicine] 2020 Oct 12; Vol. 15, pp. 7825-7840. Date of Electronic Publication: 2020 Oct 12 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Drug Compounding*
Antifungal Agents/*chemistry
Antifungal Agents/*pharmacology
Drug Carriers/*chemistry
Eye/*drug effects
Voriconazole/*chemistry
Voriconazole/*pharmacology
Animals ; Antifungal Agents/therapeutic use ; Candida albicans/drug effects ; Candida albicans/physiology ; Eye/microbiology ; Eye Infections, Fungal/drug therapy ; Gels ; Humans ; Particle Size ; Surface-Active Agents/chemistry ; Voriconazole/therapeutic use ; Water/chemistry
Czasopismo naukowe
Tytuł :
Voriconazole incorporated nanofiber formulations for topical application: preparation, characterization and antifungal activity studies against Candida species.
Autorzy :
Esentürk İ; Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.
Balkan T; Polymer Science and Technology, Istanbul Technical University, Istanbul, Turkey.; TÜPRAS Energy Center (KUTEM), Koç University, Istanbul, Turkey.
Özhan G; Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Döşler S; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Güngör S; Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Erdal MS; Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.
Sarac AS; Polymer Science and Technology, Istanbul Technical University, Istanbul, Turkey.; Nanoscience and Nanoengineering, Istanbul Technical University, Istanbul, Turkey.
Pokaż więcej
Źródło :
Pharmaceutical development and technology [Pharm Dev Technol] 2020 Apr; Vol. 25 (4), pp. 440-453. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Delivery Systems*
Antifungal Agents/*administration & dosage
Candida/*drug effects
Nanofibers/*chemistry
Voriconazole/*administration & dosage
Administration, Topical ; Alginates/chemistry ; Animals ; Antifungal Agents/pharmacokinetics ; Antifungal Agents/pharmacology ; Candidiasis/drug therapy ; Cell Line ; Drug Liberation ; Humans ; Mice ; Polyvinyl Alcohol/chemistry ; Skin Absorption ; Swine ; Voriconazole/pharmacokinetics ; Voriconazole/pharmacology
Czasopismo naukowe
Tytuł :
A 31-Year-Old Man With A Fungal Infection, Elevated Alkaline Phosphatase Level, and Polyarthritis.
Autorzy :
Khawar T; Loma Linda University, Loma Linda, California.
Hamann CR; Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Haghshenas A; Loma Linda University, Loma Linda, California.
Blackburn A; Loma Linda University, Loma Linda, California.
Torralba KD; Loma Linda University, Loma Linda, California.
Pokaż więcej
Źródło :
Arthritis care & research [Arthritis Care Res (Hoboken)] 2020 May; Vol. 72 (5), pp. 601-606.
Typ publikacji :
Case Reports; Clinical Conference; Journal Article
MeSH Terms :
Alkaline Phosphatase/*blood
Antifungal Agents/*adverse effects
Arthritis/*chemically induced
Aspergillus fumigatus/*drug effects
Bone Remodeling/*drug effects
Neuroaspergillosis/*drug therapy
Periostitis/*chemically induced
Voriconazole/*adverse effects
Adult ; Antifungal Agents/administration & dosage ; Arthritis/blood ; Arthritis/diagnosis ; Arthritis/physiopathology ; Aspergillus fumigatus/pathogenicity ; Biomarkers/blood ; Drug Substitution ; Humans ; Male ; Micafungin/administration & dosage ; Neuroaspergillosis/diagnosis ; Neuroaspergillosis/microbiology ; Periostitis/blood ; Periostitis/diagnosis ; Periostitis/physiopathology ; Risk Factors ; Treatment Outcome ; Up-Regulation ; Voriconazole/administration & dosage
Czasopismo naukowe
Tytuł :
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant.
Autorzy :
Patel JN; Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Hamadeh IS; Department of Cancer Pharmacology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Robinson M; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Shahid Z; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Symanowski J; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Steuerwald N; Molecular Biology Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Hamilton A; Molecular Biology Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Reese ES; Translational Research, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Plesca DC; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Arnall J; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Taylor M; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Trivedi J; Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Gerber J; Division of Hematology/Oncology, Department of Medicine, UMass Memorial Health Care, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Ghosh N; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Avalos B; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Mar; Vol. 107 (3), pp. 571-579. Date of Electronic Publication: 2019 Oct 26.
Typ publikacji :
Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Antifungal Agents/*administration & dosage
Cytochrome P-450 CYP2C19/*genetics
Invasive Fungal Infections/*prevention & control
Voriconazole/*administration & dosage
Adult ; Aged ; Antifungal Agents/pharmacokinetics ; Cost Savings ; Dose-Response Relationship, Drug ; Female ; Genotype ; Humans ; Invasive Fungal Infections/etiology ; Male ; Middle Aged ; Prospective Studies ; Voriconazole/pharmacokinetics
Czasopismo naukowe
Tytuł :
Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.
Autorzy :
Hicks JK; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Quilitz RE; Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Kubal TE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Pasikhova Y; Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Qin D; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
So W; Department of Pharmacy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Caceres G; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Kelly K; Department of Clinical Informatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Salchert YS; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Shahbazian K; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Abbas-Aghababazadeh F; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Fridley BL; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Velez AP; Department of Infectious Disease, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
McLeod HL; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Greene JN; Department of Infectious Disease, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Mar; Vol. 107 (3), pp. 563-570. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*administration & dosage
Cytochrome P-450 CYP2C19/*genetics
Leukemia, Myeloid, Acute/*complications
Mycoses/*prevention & control
Voriconazole/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Alleles ; Antifungal Agents/pharmacokinetics ; Dose-Response Relationship, Drug ; Female ; Genotype ; Humans ; Incidence ; Male ; Middle Aged ; Neutropenia/etiology ; Prospective Studies ; Risk Management ; Voriconazole/pharmacokinetics ; Young Adult
Czasopismo naukowe
Tytuł :
Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring.
Autorzy :
Resztak M; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Święcickiego Str., 60-781 Poznań, Poland. Electronic address: .
Kosicka K; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Święcickiego Str., 60-781 Poznań, Poland. Electronic address: .
Zalewska P; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Święcickiego Str., 60-781 Poznań, Poland. Electronic address: .
Krawiec J; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Święcickiego Str., 60-781 Poznań, Poland. Electronic address: .
Główka FK; Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 6 Święcickiego Str., 60-781 Poznań, Poland. Electronic address: .
Pokaż więcej
Źródło :
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2020 Jan 30; Vol. 178, pp. 112952. Date of Electronic Publication: 2019 Oct 25.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Antifungal Agents/*pharmacokinetics
Drug Monitoring/*methods
Mycoses/*blood
Voriconazole/*pharmacokinetics
Adolescent ; Antifungal Agents/administration & dosage ; Antifungal Agents/blood ; Child ; Child, Preschool ; Chromatography, High Pressure Liquid/methods ; Female ; Fluorescence ; Humans ; Male ; Mycoses/drug therapy ; Reproducibility of Results ; Voriconazole/administration & dosage ; Voriconazole/blood
Czasopismo naukowe
Tytuł :
Infantile Aspergillus fumigatus ventriculitis successfully treated with monitoring of plasma and cerebrospinal fluid voriconazole concentration level.
Autorzy :
Furudate A; Department of Neonatology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Hirose S; Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Abe K; Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Kawashima A; Department of Neurosurgery, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Hashimoto K; Department of Neurosurgery, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Yamazaki S; Division of Pharmacy, Chiba University Hospital, Chiba, Japan.
Kamei K; Division of Infectious Disease, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Ishiwada N; Division of Infectious Disease, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Hamada H; Department of Pediatrics, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Sato M; Department of Neonatology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2020 Jan; Vol. 26 (1), pp. 132-135. Date of Electronic Publication: 2019 Jul 23.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antifungal Agents*/blood
Antifungal Agents*/cerebrospinal fluid
Antifungal Agents*/therapeutic use
Aspergillus fumigatus*
Voriconazole*/blood
Voriconazole*/cerebrospinal fluid
Voriconazole*/therapeutic use
Cerebral Ventriculitis/*drug therapy
Neuroaspergillosis/*drug therapy
Drug Monitoring ; Humans ; Infant, Newborn ; Male
Czasopismo naukowe
Tytuł :
Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study.
Autorzy :
Blanco-Dorado S; Pharmacy Department, University Clinical Hospital Santiago de Compostela (CHUS), Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital, Santiago de Compostela, Spain.; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
Maroñas O; Genomic Medicine Group, Centro Nacional de Genotipado (CEGEN-PRB3), CIBERER, CIMUS, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Galician Foundation of Genomic Medicine, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, Santiago de Compostela, Spain.
Latorre-Pellicer A; Genomic Medicine Group, Centro Nacional de Genotipado (CEGEN-PRB3), CIBERER, CIMUS, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
Rodríguez Jato MT; Pharmacy Department, University Clinical Hospital Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
López-Vizcaíno A; Pharmacy Department, University Hospital Lucus Augusti (HULA), Lugo, Spain.
Gómez Márquez A; Pharmacy Department, University Hospital Ourense (CHUO), Ourense, Spain.
Bardán García B; Pharmacy Department, University Hospital Ferrol (CHUF), A Coruña, Spain.
Belles Medall D; Pharmacy Department, General University Hospital Castellón (GVA), Castellon, Spain.
Barbeito Castiñeiras G; Microbiology Department, University Clinical Hospital Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
Pérez Del Molino Bernal ML; Microbiology Department, University Clinical Hospital Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
Campos-Toimil M; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
Otero Espinar F; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
Blanco Hortas A; Epidemiology Unit, Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS), University Hospital Lucus Augusti (HULA), Lugo, Spain.
Durán Piñeiro G; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital, Santiago de Compostela, Spain.
Zarra Ferro I; Pharmacy Department, University Clinical Hospital Santiago de Compostela (CHUS), Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital, Santiago de Compostela, Spain.
Carracedo Á; Genomic Medicine Group, Centro Nacional de Genotipado (CEGEN-PRB3), CIBERER, CIMUS, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Galician Foundation of Genomic Medicine, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, Santiago de Compostela, Spain.
Lamas MJ; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital, Santiago de Compostela, Spain.
Fernández-Ferreiro A; Pharmacy Department, University Clinical Hospital Santiago de Compostela (CHUS), Santiago de Compostela, Spain.; Clinical Pharmacology Group, Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital, Santiago de Compostela, Spain.; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
Pokaż więcej
Źródło :
Pharmacotherapy [Pharmacotherapy] 2020 Jan; Vol. 40 (1), pp. 17-25.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Antifungal Agents/*pharmacokinetics
Cytochrome P-450 CYP2C19/*genetics
Drug-Related Side Effects and Adverse Reactions/*epidemiology
Voriconazole/*pharmacokinetics
Adult ; Antifungal Agents/administration & dosage ; Antifungal Agents/adverse effects ; Antifungal Agents/blood ; Dose-Response Relationship, Drug ; Drug Monitoring ; Drug-Related Side Effects and Adverse Reactions/genetics ; Female ; Genotype ; Humans ; Male ; Mycoses/drug therapy ; Prevalence ; Prospective Studies ; Spain/epidemiology ; Voriconazole/administration & dosage ; Voriconazole/adverse effects ; Voriconazole/blood
Czasopismo naukowe
Tytuł :
Therapeutic drug monitoring and safety of voriconazole in elderly patients.
Autorzy :
Cheng L; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China.
Xiang R; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China.
Liu F; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China.
Li Y; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China.
Chen H; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China.
Yao P; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China.
Sun F; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: .
Xia P; Department of Pharmacy, the First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing 400038, China. Electronic address: .
Pokaż więcej
Źródło :
International immunopharmacology [Int Immunopharmacol] 2020 Jan; Vol. 78, pp. 106078. Date of Electronic Publication: 2019 Dec 09.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antifungal Agents/*pharmacokinetics
Aspergillosis/*blood
Inflammation/*immunology
Invasive Fungal Infections/*blood
Voriconazole/*pharmacokinetics
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Aging/immunology ; Antifungal Agents/administration & dosage ; Antifungal Agents/adverse effects ; Aspergillosis/drug therapy ; Aspergillosis/immunology ; Dose-Response Relationship, Drug ; Drug Monitoring/statistics & numerical data ; Female ; Humans ; Inflammation/blood ; Infusions, Intravenous ; Invasive Fungal Infections/drug therapy ; Invasive Fungal Infections/immunology ; Male ; Middle Aged ; Procalcitonin/blood ; Retrospective Studies ; Voriconazole/administration & dosage ; Voriconazole/adverse effects
Czasopismo naukowe
Tytuł :
Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.
Autorzy :
Yamada T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Mino Y; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Naito T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan. Electronic address: .
Kawakami J; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2019 Dec; Vol. 25 (12), pp. 1019-1025. Date of Electronic Publication: 2019 Jun 22.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Antifungal Agents/*adverse effects
Chemical and Drug Induced Liver Injury/*epidemiology
Cytochrome P-450 CYP2C19/*genetics
Oxygenases/*genetics
Voriconazole/*adverse effects
Administration, Oral ; Aged ; Antifungal Agents/administration & dosage ; Antifungal Agents/pharmacokinetics ; Chemical and Drug Induced Liver Injury/diagnosis ; Chemical and Drug Induced Liver Injury/genetics ; Cytochrome P-450 CYP2C19/metabolism ; Female ; Genotype ; Humans ; Immunocompromised Host/drug effects ; Immunocompromised Host/genetics ; Incidence ; Japan/epidemiology ; Liver Function Tests ; Male ; Middle Aged ; Mycoses/drug therapy ; Oxygenases/metabolism ; Voriconazole/administration & dosage ; Voriconazole/pharmacokinetics
Czasopismo naukowe
Tytuł :
Iontophoresis enhances voriconazole antifungal potency and corneal penetration.
Autorzy :
Gelfuso GM; Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, 70910-900 Brasília, DF, Brazil.
Ferreira-Nunes R; Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, 70910-900 Brasília, DF, Brazil.
Dalmolin LF; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.
Dos S Ré AC; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.
Dos Santos GA; Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, 70910-900 Brasília, DF, Brazil.
de Sá FAP; Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, 70910-900 Brasília, DF, Brazil.
Cunha-Filho M; Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, 70910-900 Brasília, DF, Brazil.
Alonso A; Institute of Physics - Catalão Reginal, Federal University of Goiás (UFG), 75704-020 Catalão, GO, Brazil.
Neto SAM; Institute of Physics, Federal University of Goiás (UFG), 74690-900 Goiânia, GO, Brazil.
Anjos JLV; Institute of Physics, Federal University of Goiás (UFG), 74690-900 Goiânia, GO, Brazil.
Aires CP; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.
Lopez RFV; School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.
Gratieri T; Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, 70910-900 Brasília, DF, Brazil. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2020 Feb 25; Vol. 576, pp. 118991. Date of Electronic Publication: 2019 Dec 26.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Iontophoresis*
Antifungal Agents/*administration & dosage
Candida glabrata/*drug effects
Cornea/*metabolism
Voriconazole/*administration & dosage
Administration, Ophthalmic ; Animals ; Antifungal Agents/chemistry ; Antifungal Agents/metabolism ; Candida glabrata/growth & development ; Chitosan/chemistry ; Cyclodextrins/chemistry ; Drug Compounding ; Lipids/chemistry ; Liposomes ; Microbial Sensitivity Tests ; Nanoparticles ; Sus scrofa ; Tissue Distribution ; Voriconazole/chemistry ; Voriconazole/metabolism
Czasopismo naukowe
Tytuł :
Pharmacokinetic/Pharmacodynamic Analysis of Voriconazole Against Candida spp. and Aspergillus spp. in Allogeneic Stem Cell Transplant Recipients.
Autorzy :
Perez-Pitarch A; Pharmacy Department, University Clinical Hospital of Valencia, Valencia, Spain.
Guglieri-Lopez B; Pharmacy Department, Doctor Peset University Hospital, Valencia, Spain.
Ferriols-Lisart R; Pharmacy Department, University Clinical Hospital of Valencia, Valencia, Spain.
Pérez A; Haematology Department, University Clinical Hospital of Valencia, Valencia, Spain. Dr. Piñana Is now with the Haematology Service, Hospital Universitario y Politécnico Louisiana Fe, Valencia, Spain.
Ezquer-Garín C; Institute for Health Research (INCLIVA), University Clinical Hospital of Valencia, Valencia, Spain.
Hernández-Boluda JC; Haematology Department, University Clinical Hospital of Valencia, Valencia, Spain. Dr. Piñana Is now with the Haematology Service, Hospital Universitario y Politécnico Louisiana Fe, Valencia, Spain.
Piñana JL; Haematology Department, University Clinical Hospital of Valencia, Valencia, Spain. Dr. Piñana Is now with the Haematology Service, Hospital Universitario y Politécnico Louisiana Fe, Valencia, Spain.
Navarro D; Microbiology Service, Hospital Clínico Universitario, Valencia, Spain.
Solano C; Haematology Department, University Clinical Hospital of Valencia, Valencia, Spain. Dr. Piñana Is now with the Haematology Service, Hospital Universitario y Politécnico Louisiana Fe, Valencia, Spain.
Alós-Almiñana M; Pharmacy Department, University Clinical Hospital of Valencia, Valencia, Spain.
Pokaż więcej
Źródło :
Therapeutic drug monitoring [Ther Drug Monit] 2019 Dec; Vol. 41 (6), pp. 740-747.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antifungal Agents/*pharmacokinetics
Aspergillosis/*microbiology
Candidiasis/*microbiology
Stem Cell Transplantation/*adverse effects
Voriconazole/*pharmacokinetics
Administration, Oral ; Adult ; Aged ; Allografts ; Antifungal Agents/administration & dosage ; Antifungal Agents/therapeutic use ; Aspergillosis/prevention & control ; Aspergillus/drug effects ; Candida/drug effects ; Candidiasis/prevention & control ; Dose-Response Relationship, Drug ; Female ; Humans ; Male ; Middle Aged ; Monte Carlo Method ; Voriconazole/administration & dosage ; Voriconazole/therapeutic use
Czasopismo naukowe
Tytuł :
Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China.
Autorzy :
Guo J; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Li BK; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Li TM; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Wei FL; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Fu YJ; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Zheng YQ; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Pan KS; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Huang CY; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China.
Cao CW; Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, People's Republic of China. .; The Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, No 22, Shuang Yong Road, Nanning, 530022, People's Republic of China. .
Pokaż więcej
Źródło :
Mycopathologia [Mycopathologia] 2019 Dec; Vol. 184 (6), pp. 735-745. Date of Electronic Publication: 2019 Aug 31.
Typ publikacji :
Journal Article
MeSH Terms :
AIDS-Related Opportunistic Infections*/drug therapy
AIDS-Related Opportunistic Infections*/immunology
AIDS-Related Opportunistic Infections*/microbiology
AIDS-Related Opportunistic Infections*/mortality
Mycoses*/drug therapy
Mycoses*/immunology
Mycoses*/microbiology
Mycoses*/mortality
Talaromyces*/drug effects
Talaromyces*/pathogenicity
Voriconazole/*therapeutic use
Antifungal Agents/adverse effects ; Antifungal Agents/therapeutic use ; Child ; Child, Preschool ; China ; Female ; HIV-1 ; Humans ; Infant ; Itraconazole/adverse effects ; Itraconazole/therapeutic use ; Male ; Retrospective Studies ; Voriconazole/adverse effects
SCR Disease Name :
talaromycosis
Czasopismo naukowe
Tytuł :
Prolonged-Release Tacrolimus Is Less Susceptible to Interaction With the Strong CYP3A Inhibitor Voriconazole in Healthy Volunteers.
Autorzy :
Huppertz A; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Ott C; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Bruckner T; Department of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
Foerster KI; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Burhenne J; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Weiss J; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Zorn M; Central Laboratory, University Hospital Heidelberg, Heidelberg, Germany.
Haefeli WE; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Czock D; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Pokaż więcej
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2019 Dec; Vol. 106 (6), pp. 1290-1298. Date of Electronic Publication: 2019 Jul 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cytochrome P-450 CYP3A Inhibitors/*pharmacokinetics
Tacrolimus/*pharmacokinetics
Voriconazole/*pharmacokinetics
Adult ; Area Under Curve ; Cytochrome P-450 CYP3A/genetics ; Cytochrome P-450 CYP3A/metabolism ; Cytochrome P-450 CYP3A Inhibitors/adverse effects ; Delayed-Action Preparations ; Drug Interactions ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Tacrolimus/administration & dosage ; Tacrolimus/adverse effects ; Voriconazole/adverse effects ; Young Adult
Czasopismo naukowe
Tytuł :
Twice-Weekly Tacrolimus Can Overcome Pharmacologic Interaction and Help in the Successful Treatment of Pulmonary Aspergillosis in a Liver Transplant Recipient.
Autorzy :
Chiu YC; From the Division of General Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Ho MH
Chen TW
Hsieh CB
Fan HL
Pokaż więcej
Źródło :
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation [Exp Clin Transplant] 2019 Dec; Vol. 17 (6), pp. 838-840. Date of Electronic Publication: 2018 Oct 24.
Typ publikacji :
Case Reports
MeSH Terms :
Liver Transplantation*
Antifungal Agents/*therapeutic use
Calcineurin Inhibitors/*administration & dosage
Graft Rejection/*prevention & control
Immunosuppressive Agents/*administration & dosage
Opportunistic Infections/*drug therapy
Pulmonary Aspergillosis/*drug therapy
Tacrolimus/*administration & dosage
Voriconazole/*administration & dosage
Antifungal Agents/adverse effects ; Calcineurin Inhibitors/adverse effects ; Drug Administration Schedule ; Drug Interactions ; Drug Monitoring ; Graft Rejection/immunology ; Graft Survival/drug effects ; Humans ; Immunocompromised Host ; Immunosuppressive Agents/adverse effects ; Male ; Middle Aged ; Opportunistic Infections/diagnosis ; Opportunistic Infections/microbiology ; Pulmonary Aspergillosis/diagnosis ; Pulmonary Aspergillosis/microbiology ; Tacrolimus/adverse effects ; Treatment Outcome ; Voriconazole/adverse effects
Raport
Tytuł :
Voriconazole-Based Salts Are Active against Multidrug-Resistant Human Pathogenic Yeasts.
Autorzy :
Szepiński E; Department of Organic Chemistry, Gdańsk University of Technology, 11/12 G. Narutowicza Str., 80-233 Gdańsk, Poland. .
Martynow D; Department of Pharmaceutical Technology and Biochemistry, Gdańsk University of Technology, 11/12 G. Narutowicza Str., 80-233 Gdańsk, Poland. .
Szweda P; Department of Pharmaceutical Technology and Biochemistry, Gdańsk University of Technology, 11/12 G. Narutowicza Str., 80-233 Gdańsk, Poland. .
Milewska MJ; Department of Organic Chemistry, Gdańsk University of Technology, 11/12 G. Narutowicza Str., 80-233 Gdańsk, Poland. .
Milewski S; Department of Pharmaceutical Technology and Biochemistry, Gdańsk University of Technology, 11/12 G. Narutowicza Str., 80-233 Gdańsk, Poland. .
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2019 Oct 09; Vol. 24 (20). Date of Electronic Publication: 2019 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Antifungal Agents/*pharmacology
Drug Resistance, Fungal/*drug effects
Salts/*pharmacology
Voriconazole/*pharmacology
ATP-Binding Cassette Transporters/metabolism ; Antifungal Agents/chemistry ; Antifungal Agents/metabolism ; Biological Transport ; Dose-Response Relationship, Drug ; Humans ; Microbial Sensitivity Tests ; Salts/chemistry ; Salts/metabolism ; Voriconazole/chemistry ; Voriconazole/metabolism
Czasopismo naukowe
Tytuł :
Injectable Schiff base polysaccharide hydrogels for intraocular drug loading and release.
Autorzy :
Yang C; Material Science and Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.; Institute of Complexity Science, Automation College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.
Gao L; Material Science and Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.
Liu X; Marine Chemical Research Institute, Qingdao, Shandong, 266071, People's Republic of China.
Yang T; Material Science and Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.
Yin G; Material Science and Engineering College, Beijing University of Chemical Technology, Beijing, 100029, People's Republic of China.
Chen J; Material Science and Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.
Guo H; Material Science and Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.
Yu B; Chemistry and Chemical Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.
Cong H; Material Science and Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.; Chemistry and Chemical Engineering College, Qingdao University, Qingdao, Shandong, 266071, People's Republic of China.
Pokaż więcej
Źródło :
Journal of biomedical materials research. Part A [J Biomed Mater Res A] 2019 Sep; Vol. 107 (9), pp. 1909-1916. Date of Electronic Publication: 2019 Apr 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hydrogels*/chemistry
Hydrogels*/pharmacokinetics
Hydrogels*/pharmacology
Polysaccharides*/chemistry
Polysaccharides*/pharmacokinetics
Polysaccharides*/pharmacology
Voriconazole*/chemistry
Voriconazole*/pharmacokinetics
Voriconazole*/pharmacology
Delayed-Action Preparations/chemistry ; Delayed-Action Preparations/pharmacokinetics ; Delayed-Action Preparations/pharmacology ; Humans ; Injections, Intraocular ; Schiff Bases/chemistry ; Schiff Bases/pharmacokinetics ; Schiff Bases/pharmacology
Czasopismo naukowe
Tytuł :
Case Report: Chronic Fungal Meningitis Masquerading as Tubercular Meningitis.
Autorzy :
Hesarur N; Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Seshagiri DV; Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Nagappa M; Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Rao S; Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Santosh V; Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Chandrashekar N; Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Reddy N; Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Sharma PP; Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Kumari P; Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Pruthi N; Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Shukla D; Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Saini J; Neuroimaging and Interventional Radiology (NIIR), National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Taly AB; Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Sinha S; Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Pokaż więcej
Źródło :
The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2020 Oct; Vol. 103 (4), pp. 1473-1479.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Diagnosis, Differential*
Brain Abscess/*microbiology
Meningitis/*pathology
Meningitis, Fungal/*diagnosis
Tuberculosis, Meningeal/*diagnosis
Amphotericin B/administration & dosage ; Amphotericin B/therapeutic use ; Antifungal Agents/administration & dosage ; Antifungal Agents/therapeutic use ; Antitubercular Agents/therapeutic use ; Ascomycota/isolation & purification ; Brain/pathology ; Brain Abscess/pathology ; Humans ; Male ; Meningitis, Fungal/drug therapy ; Middle Aged ; Phaeohyphomycosis/diagnosis ; Steroids/therapeutic use ; Tuberculosis, Meningeal/drug therapy ; Voriconazole/administration & dosage ; Voriconazole/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies